Article info

Download PDFPDF

Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial

Authors

  • Beatriz González-Rodríguez Ophthalmology, Retina Service, Complejo Hospitalario de Toledo, Servicio de Salud de Castilla-La Mancha, Toledo, Spain PubMed articlesGoogle scholar articles
  • Karina Villar Gómez de las Heras DG Asistencia Sanitaria, Servicio de Salud de Castilla-La Mancha, Toledo, SpainAlianza VHL, Alianza de Familias de von Hippel-Lindau, Toledo, Spain PubMed articlesGoogle scholar articles
  • Daniel T Aguirre Neurosurgery, Familial Neuro-Oncology Unit, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain PubMed articlesGoogle scholar articles
  • Luis Rodríguez-Padial Cardiology, Complejo Hospitalario de Toledo, Servicio de Salud de Castilla-La Mancha, Toledo, Spain PubMed articlesGoogle scholar articles
  • Virginia Albiñana Centro de Investigaciones Biológicas—CIB, Centro Superior de Investigaciones Científicas (CSIC), Madrid, SpainCentro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain PubMed articlesGoogle scholar articles
  • Lucía Recio-Poveda Centro de Investigaciones Biológicas—CIB, Centro Superior de Investigaciones Científicas (CSIC), Madrid, Spain PubMed articlesGoogle scholar articles
  • Angel M Cuesta Centro de Investigaciones Biológicas—CIB, Centro Superior de Investigaciones Científicas (CSIC), Madrid, SpainCentro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain PubMed articlesGoogle scholar articles
  • Luisa Mª Botella Centro de Investigaciones Biológicas—CIB, Centro Superior de Investigaciones Científicas (CSIC), Madrid, SpainCentro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain PubMed articlesGoogle scholar articles
  • Rosa María Jiménez-Escribano Ophthalmology, Retina Service, Complejo Hospitalario de Toledo, Servicio de Salud de Castilla-La Mancha, Toledo, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Karina Villar Gómez de las Heras; kvillar{at}jccm.es
View Full Text

Citation

González-Rodríguez B, Villar Gómez de las Heras K, Aguirre DT, et al
Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial

Publication history

  • First published May 28, 2019.
Online issue publication 
May 28, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.